Kirkland & Ellis advised Blackstone on the transaction, and Goodwin Procter advised TA Associates, alongside Fortissimo. Blackstone announced that Blackstone Growth and affiliated funds (collectively “Blackstone”)...
You must be a Standard 1 Year member to access this content.
Goodwin advised NREP on the fundraising. Urban Partners’ Northern European real estate business NREP announced the closing of NREP Nordic Strategies Fund V SCSp which has...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Bicara Therapeutics on the deal. Bicara Therapeutics announced the completion of its oversubscribed $108 million Series B financing to advance the company’s lead program...
You must be a Standard 1 Year member to access this content.
Goodwin advised Intermediate Capital Group on the deal. Intermediate Capital Group announced the structuring and fundraising of its eighth European Corporate fund. The Fund held a final...
You must be a Standard 1 Year member to access this content.
Freshfields Bruckhaus Deringer advised international private equity firm Cinven on the deal. Travers Smith LLP advised the management team of Premium Credit. Goodwin represented TowerBrook Capital...
You must be a Standard 1 Year member to access this content.
Goodwin Procter and Travers Smith advised Abingworth on the deal, while Debevoise & Plimpton advised Carlyle. Abingworth announced its proposed acquisition by global investment firm Carlyle (NASDAQ:...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Ares Management Corporation on the deal. Ares Management Corporation (NYSE:ARES) announced the final closing of Ares European Property Enhancement Partners III SCSp (“EPEP III”...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Sentenial Limited on the deal. EML Payments was represented by Arthur Cox and Herbert Smith Freehills LLP. Sentenial Limited announced its sale to...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Abingworth on the deal. Abingworth announced the formation of its latest transatlantic venture fund, Abingworth Bioventures 8 (ABV 8), which closed at...
You must be a Standard 1 Year member to access this content.
